NeuPath Health Inc.
NPTH.V
TSX
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -2.64% | -0.89% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.64% | -0.89% | |||
| Cost of Revenue | -2.69% | 0.00% | |||
| Gross Profit | -2.42% | -4.68% | |||
| SG&A Expenses | -26.81% | 9.03% | |||
| Depreciation & Amortization | -3.29% | -0.15% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.51% | 1.32% | |||
| Operating Income | 12,298.00% | -98.59% | |||
| Income Before Tax | 224.12% | -1,589.56% | |||
| Income Tax Expenses | 302.53% | -136.57% | |||
| Earnings from Continuing Operations | 213.73% | -251.32% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 11.71% | -25.70% | |||
| Net Income | 176.72% | -164.09% | |||
| EBIT | 12,298.00% | -98.59% | |||
| EBITDA | 70.00% | -21.74% | |||
| EPS Basic | 176.92% | -160.00% | |||
| Normalized Basic EPS | 280.00% | -266.67% | |||
| EPS Diluted | 176.92% | -160.00% | |||
| Normalized Diluted EPS | 272.00% | -266.67% | |||
| Average Basic Shares Outstanding | 0.14% | -0.41% | |||
| Average Diluted Shares Outstanding | 5.47% | -3.51% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||